Beauty Farm Medical and Health Industry Inc. disclosed a share buy-back executed on 3 September 2026, repurchasing 33,500 ordinary shares on the Stock Exchange of Hong Kong.

The transaction was carried out at prices ranging from HKD 17.68 to HKD 18.05 per share, with a volume-weighted average cost of HKD 17.86. The total consideration amounted to HKD 0.60 million.

Following the repurchase, the company’s issued share capital (excluding treasury shares) decreased to 247.96 million shares, while treasury shares increased to 3.63 million. The repurchased shares equal 0.0135 % of the issuer’s outstanding share count before the transaction.

Under the general mandate approved on 26 June 2026, Beauty Farm Medical is authorised to repurchase up to 24.85 million shares. Cumulative buy-backs since the mandate now total 559,500 shares, equivalent to 0.23 % of the company’s issued share base at the mandate date.

A 30-day moratorium on new share issues or treasury-share sales is in effect until 3 October 2026, in accordance with Hong Kong Stock Exchange rules.